Navigation Links
Actos Lawsuit News: Bernstein Liebhard LLP Notes Start of Second Actos Bladder Cancer Trial in Maryland State Court
Date:9/4/2013

New York, New York (PRWEB) September 04, 2013

Thousands of Actos lawsuits (http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) that allege long-term use of the Type 2 diabetes drug caused patients to develop bladder cancer continue to move forward in courts throughout the country, Bernstein Liebhard LLP reports. According to court documents, opening statements in the nation’s second trail involving Actos bladder cancer allegations got underway yesterday in Maryland state court, with a lawyer for the Plaintiff accusing Takeda Pharmaceutical Co. of placing the drug’s sales ahead of patient safety. (An v. Nieberlein, 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland.)

“Our Firm continues to hear from long-term Actos users whose experiences with the medication echo the allegations that will be put forth during this trial. We hope this proceeding will provide valuable insights into the way juries could rule in similar Actos lawsuits,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free lawsuit evaluations to individuals who were diagnosed with bladder cancer following long-term use of Actos.

Actos Lawsuits

Court documents indicate that more than 3,000 Actos bladder cancer claims are currently pending in courts throughout the U.S., the majority of which have been filed in a federal multidistrict litigation underway in U.S. District Court, Western District of Louisiana. That litigation’s first bellwether trial will begin on January 27, 2014, while the second will commence on April 14, 2014. (In re: Actos Product Liability Litigation, MDL No. 2299)

The case underway in Maryland was filed on behalf of a Vietnamese immigrant who died of bladder cancer last
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. National Actos Attorneys File Lawsuit on Behalf of Louisiana Woman who Developed Bladder Cancer Allegedly Due to The Diabetes Drug Actos
2. Victim’s Rights to Recover for Actos Bladder Cancer Could Expire Soon
3. Actos Bladder Cancer Lawsuit Filed in Louisiana Alleging Woman Used Diabetes Medication and Contracted Bladder Cancer, Consumer Justice Foundation Reports
4. Researchers Offer Explanation for Actos Bladder Cancer Risk
5. New Lawsuit alleges Actos caused Bladder Cancer
6. US Drug Watchdog Now Urges Family Members Of A Diabetic Who Died From Bladder Cancer After Using The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
7. US Drug Watchdog Now Urges Users Of The Diabetes Drug Called Actos To Call The Johnson Law Group if They Have Developed Bladder Cancer-Time Is Of The Essence
8. US Drug Watchdog Now Urges Any US Citizen Who Used the Diabetes Drug Called Actos and Then Developed Bladder Cancer To Contact The Johnson Law Group For A Legal Review
9. US Drug Watchdog Now Urges Loved Ones Of A Diabetic Who Died From Bladder Cancer Who Had Used The Diabetes Drug Called Actos To Call The Johnson Law Group Immediately
10. US Drug Watchdog Now Expands Their Efforts to Educate Diabetics About the Diabetes Drug Actos and Bladder Cancer, with the Suggestion Victims Call the Johnson Law Group
11. US Drug Watchdog Now Urges Any Diabetic Who Used the Diabetes Drug Actos and Now Have Been Diagnosed with Bladder Cancer to Call The Johnson Law Group-ASAP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... October 20, 2014 Zereana Jess-Huff, a 34-year-old ... Maryland 2014 on a platform to think outside the bra. ... uses her position to raise awareness about women’s other lady ... breast cancer. You say the color pink and everybody knows ... for a fact that it has not been won when ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Principle Business ... takes pride in manufacturing top-of-the-line absorbent products. The ... of its most popular brand, Tranquility® Premium Protection absorbent ... a new website, gave its packaging a new look, ... the brand message to the public. , The new ...
(Date:10/20/2014)... Rockynol Retirement Community broke ground ... The $11 million project will include the latest in ... with full-service restaurant style dining. , “We are excited ... Assisted Living apartments,” said Kara Hanzie, Rockynol Executive Director ... of care and this investment is proof of our ...
(Date:10/20/2014)... National Teen Driver Safety Week is October 19-25, ... Pediatrics (Ohio AAP, http://www.ohioaap.org ) is joining the National ... drivers to talk to their teens and always set the ... are the leading cause of death for U.S. teens. In ... and 859 (42%) of those teen drivers were killed in ...
(Date:10/20/2014)... It’s hard to imagine what it’s like to live without ... world, it’s a reality. And while new shoes are considered ... walk barefoot on rocky terrain or sewage-lined streets just to ... , Buckner International's Shoes for Orphan Souls ... to encourage support for Air1 and while also providing new ...
Breaking Medicine News(10 mins):Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3
... Criminal Fine is Largest Individual Corporate Criminal Fine in ... American pharmaceutical giant Eli Lilly and Company today agreed ... its drug Zyprexa for uses not approved by the ... announced today. This resolution includes a criminal ...
... Jan. 15 For the first time in Ohio,s,history, ... in a,statewide effort to make Ohio the safest place ... The Cardinal Health Foundation, the Ohio Business ... and the Ohio Children,s,Hospital Association today announced the formation ...
... to Private FirmsPHILADELPHIA, Jan. 15 /PRNewswire/ -- ... Communications for Centocor, Inc., an operating company of ... of a public relations consultancy, Pitch360 Incorporated ( ... communications, and issues management consultancy that leverages its ...
... BOSTON ─ (January 15, 2009) Tufts University has ... Health (NIH) to design an obesity prevention program ... D. Economos, PhD, the clinical trial will randomize ... age children living in Somerville, Mass., and follow ...
... nonpartisan Employee Benefit Research Institute (EBRI) today published a ... involved in capping the tax exclusion for employment-based health ... year,s expected debate over overhauling the nation,s health care ... been a policy goal of both parties as far ...
... Health Group announced today that in the year ... hospitals with local employers reached more than 70,000 ... rising healthcare costs as America confronts such growing ... At the same time, hospitals partnering with Aegis ...
Cached Medicine News:Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 2Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 3Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 4Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 5Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 6Health News:Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-Label Promotion of Zyprexa 7Health News:Ohio Business, Health Care Leaders Join Together to Improve Patient Safety, Reduce Costs in Ohio Hospitals 2Health News:Ohio Business, Health Care Leaders Join Together to Improve Patient Safety, Reduce Costs in Ohio Hospitals 3Health News:Former Johnson & Johnson Executive Gives Big Voice to Small Companies 2Health News:Tufts receives NIH grant to study obesity prevention in new immigrants 2Health News:Tufts receives NIH grant to study obesity prevention in new immigrants 3Health News:New Research From EBRI: Study Examines Issues in Capping Tax Exclusion of Health Coverage 2Health News:Hospital-Employer Partnerships Growing as Employers Seek Ways to Improve Health and Manage Dollars in Tough Economic Times 2
(Date:10/17/2014)... 17, 2014 A victim of medical negligence at ... doctor with a history of alcohol abuse, a physician and ... Prop 46 today, highlighting how Prop 46 will identify and ... The ad pictures a doctor drinking at ... ER."  Proposition 46 will enact the first law in the ...
(Date:10/17/2014)... Oct. 17, 2014  Talyst, a market leader in ... Annual Meeting in Nashville, TN. ... market leading solution for onsite, remote medication dispensing. ... facilities to safely and securely dispense medication onsite, on ... dose, helps ensure that the correct medication gets to ...
(Date:10/17/2014)... -- Ameritox SM , the nation,s leader in medication monitoring ... , M.D., as Chief Medical Officer. In this role, ... for healthcare providers, patients and managed care plans.   ... variety of healthcare companies that have provided him with ... health sides of Ameritox,s business. He most recently served ...
Breaking Medicine Technology:Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 2Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 4Talyst Exhibits at LeadingAge Annual Meeting 2Ameritox Appoints New Chief Medical Officer 2
... N.J. , May 27 Tibotec Therapeutics, a ... launch of the HIV Case Manager Portal (the ... designed to help HIV/AIDS front-line service providers meet their daily ... in Denver, CO at the 22nd National Conference ...
... May 26 Results of clinical studies ... Staccato® loxapine (AZ-004) reduced agitation in patients, regardless of ... levels were observed as early as 10 minutes after ... by the Positive and Negative Syndrome Scale - Excited ...
Cached Medicine Technology:Tibotec Therapeutics Debuts Innovative Web Portal for HIV/AIDS Front-Line Service Providers 2Tibotec Therapeutics Debuts Innovative Web Portal for HIV/AIDS Front-Line Service Providers 3Tibotec Therapeutics Debuts Innovative Web Portal for HIV/AIDS Front-Line Service Providers 4Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder 2Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder 3Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder 4Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder 5Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder 6Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder 7Staccato(R) Loxapine (AZ-004) Reduced Signs and Symptoms of Agitation as Early as Ten Minutes After Dosing in Patients with Schizophrenia or Bipolar Disorder 8
Infusion Cannula, 4.0mm....
Subretinal Injection Cannula, Curved; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 35°....
Subretinal Fluid Cannula, Straight; 20g (0.90) x 1-1/2" (38mm); 12mm Flexible Tubing Extends 6mm Beyond Tip....
Micro Vitreoretinal Cannula; Angled; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 65°, 1mm from Tip....
Medicine Products: